13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001420506-23-001125
Total Value
$1.38B
Positions
49
Other Managers
0
Confidential Omitted
No
Holdings (49)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HILLEVAX INC | 43157M102 | 9,781,472 | $161.7M | 11.71% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 9,341,551 | $125.6M | 9.09% |
| 3 | CHINOOK THERAPEUTICS INC | 16961L106 | 4,345,559 | $100.6M | 7.28% |
| 4 | Arcutis Biotherapeutics | ARQT | 8,684,232 | $95.5M | 6.92% |
| 5 | Mirum Pharmaceuticals, Inc. | MIRM | 3,860,107 | $92.7M | 6.71% |
| 6 | Syndax Pharmaceuticals, Inc. | SNDX | 3,708,838 | $78.3M | 5.67% |
| 7 | KRYSTAL BIOTECH INC | KRYS | 945,407 | $75.7M | 5.48% |
| 8 | Phathom Pharmaceuticals, Inc. | PHAT | 8,407,152 | $60.0M | 4.35% |
| 9 | VERONA PHARMA PLC | 925050106 | 2,944,349 | $59.1M | 4.28% |
| 10 | Vaxcyte, Inc. | PCVX | 1,397,405 | $52.4M | 3.79% |
| 11 | RHYTHM PHARMACEUTICALS INC | RYTM | 2,164,739 | $38.6M | 2.80% |
| 12 | KALVISTA PHARMACEUTICALS INC | KALV | 3,238,859 | $25.5M | 1.84% |
| 13 | COGENT BIOSCIENCES INC | COGT | 2,159,154 | $23.3M | 1.69% |
| 14 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 2,985,757 | $23.1M | 1.67% |
| 15 | TYRA BIOSCIENCES INC | TYRA | 1,421,310 | $22.8M | 1.65% |
| 16 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,414,823 | $22.7M | 1.65% |
| 17 | Tarsus Pharmaceuticals, Inc. | TARS | 1,787,527 | $22.5M | 1.63% |
| 18 | THESEUS PHARMACEUTICALS INC | 88369M101 | 2,248,194 | $20.0M | 1.45% |
| 19 | ANAPTYSBIO INC | ANABV | 899,700 | $19.6M | 1.42% |
| 20 | BRIDGEBIO PHARMA INC | BBIO | 1,171,650 | $19.4M | 1.41% |
| 21 | REVOLUTION MEDICINES INC | RVMDW | 854,484 | $18.5M | 1.34% |
| 22 | ENLIVEN THERAPEUTICS INC | ELVN | 830,983 | $18.2M | 1.32% |
| 23 | ACADIA PHARMACEUTICALS INC | ACAD | 857,338 | $16.1M | 1.17% |
| 24 | GRITSTONE BIO INC | 39868T105 | 5,162,348 | $14.4M | 1.04% |
| 25 | MERUS N V | N5749R100 | 746,479 | $13.7M | 0.99% |
| 26 | TREVI THERAPEUTICS INC | TRVI | 6,663,590 | $12.3M | 0.89% |
| 27 | MACROGENICS INC | MGNX | 1,703,204 | $12.2M | 0.88% |
| 28 | REPLIMUNE GROUP INC | REPL | 686,762 | $12.1M | 0.88% |
| 29 | VECTIVBIO HLDG AG | H9060V101 | 1,352,199 | $11.6M | 0.84% |
| 30 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 393,000 | $9.6M | 0.69% |
| 31 | Immunovant, Inc. | IMVT | 585,759 | $9.1M | 0.66% |
| 32 | SUTRO BIOPHARMA INC | STRO | 1,776,479 | $8.2M | 0.59% |
| 33 | MORPHIC HLDG INC | 61775R105 | 214,240 | $8.1M | 0.58% |
| 34 | ARVINAS INC | ARVN | 285,331 | $7.8M | 0.56% |
| 35 | AVIDITY BIOSCIENCES INC | 05370A108 | 500,000 | $7.7M | 0.56% |
| 36 | INTELLIA THERAPEUTICS INC | NTLA | 203,684 | $7.6M | 0.55% |
| 37 | AUTOLUS THERAPEUTICS PLC | AUTL | 3,746,857 | $6.9M | 0.50% |
| 38 | AEROVATE THERAPEUTICS INC | 008064107 | 338,110 | $6.8M | 0.49% |
| 39 | PROTHENA CORP PLC | PRTA | 127,900 | $6.2M | 0.45% |
| 40 | ZYMEWORKS INC | ZYME | 610,000 | $5.5M | 0.40% |
| 41 | SILENCE THERAPEUTICS PLC | SLNCF | 881,173 | $5.5M | 0.40% |
| 42 | ALLAKOS INC | 01671P100 | 1,112,684 | $5.0M | 0.36% |
| 43 | BLUEBIRD BIO INC | 09609G100 | 1,440,757 | $4.6M | 0.33% |
| 44 | EDGEWISE THERAPEUTICS INC | EWTX | 682,461 | $4.6M | 0.33% |
| 45 | Passage Bio, Inc. | PASG | 3,756,915 | $3.6M | 0.26% |
| 46 | ADC THERAPEUTICS SA | ADCT | 1,647,030 | $3.2M | 0.23% |
| 47 | ACLARIS THERAPEUTICS INC | ACRS | 264,377 | $2.1M | 0.15% |
| 48 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $920,613 | 0.07% |
| 49 | NABRIVA THERAPEUTICS PLC | G63637139 | 17,025 | $29,741 | 0.00% |